Matches in Nanopublications for { ?s ?p "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP122131.RAkKTAzRb79elUXBThSb1uiuZ_lvleXUfH2Rb0c1vqekQ130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122131.RAkKTAzRb79elUXBThSb1uiuZ_lvleXUfH2Rb0c1vqekQ130_provenance.
- NP122150.RAhfRmIej1myJysVNj1mOkbL8x7q-kPE-q35xUTkVJSrs130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122150.RAhfRmIej1myJysVNj1mOkbL8x7q-kPE-q35xUTkVJSrs130_provenance.
- assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.
- NP185338.RAvXjfbPr5GRyC7Is8Cy60XhfVmsRKM5nmEa3DDCOoedU130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185338.RAvXjfbPr5GRyC7Is8Cy60XhfVmsRKM5nmEa3DDCOoedU130_provenance.
- NP237996.RAnXdiep907WHHYpWsErkU-PbVAiLpmVLIULrjMUxD3Qc130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237996.RAnXdiep907WHHYpWsErkU-PbVAiLpmVLIULrjMUxD3Qc130_provenance.
- NP237997.RAOistIRGALa7YRDEdMLPYHKF1qH8sDQ3e0Ag0hvA91xM130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237997.RAOistIRGALa7YRDEdMLPYHKF1qH8sDQ3e0Ag0hvA91xM130_provenance.